Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LGND | AKRO | SYRE | ||
| Company | Ligand Pharm | Akero Therapeutics Inc | Spyre Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 73.53 | 20.32 | 37.00 | ||
| High | 74.17 | 20.75 | 39.04 | ||
| Low | 72.57 | 19.63 | 35.17 | ||
| Last | 73.90 | 19.66 | 35.78 | ||
| Change | +1.58 | -0.05 | -0.49 | ||
| % Change | +2.18% | -0.25% | -1.35% | ||
| Volume | 141,700 | 543,500 | 196,800 | ||
| 20-Day Average Volume | 150,445 | 695,735 | 325,645 | ||
| Previous Close | 72.32 | 19.71 | 36.27 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 74.83 | 20.94 | 35.36 | ||
| 20-Day Raw Stochastic | 44.11% | 26.26% | 47.15% | ||
| 20-Day Relative Strength | 50.42% | 37.86% | 52.30% | ||
| Weighted Alpha | +0.19 | +5.03 | +134.00 | ||
| Today's Opinion | 56% Buy | 72% Sell | 56% Buy | ||
| Previous Opinion | 40% Buy | 72% Sell | 72% Buy | ||
| Last Month's Opinion | 80% Buy | 40% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.72% since 04/26/24 | -0.41% since 04/26/24 | +6.62% since 04/26/24 | ||
| Low | 69.51 on 05/01/24 | 19.31 on 04/29/24 | 31.39 on 05/01/24 | ||
| High | 74.17 on 05/03/24 | 20.75 on 05/03/24 | 39.04 on 05/03/24 | ||
| 1-Month | |||||
| %Chg | -1.11% since 04/03/24 | -15.19% since 04/03/24 | +3.23% since 04/03/24 | ||
| Low | 67.72 on 04/22/24 | 18.20 on 04/25/24 | 31.27 on 04/25/24 | ||
| High | 81.73 on 04/12/24 | 23.89 on 04/04/24 | 40.83 on 04/12/24 | ||
| 3-Month | |||||
| %Chg | -0.86% since 02/02/24 | -5.53% since 02/02/24 | +39.01% since 02/02/24 | ||
| Low | 67.72 on 04/22/24 | 15.32 on 02/06/24 | 20.07 on 02/22/24 | ||
| High | 94.57 on 02/27/24 | 37.00 on 03/04/24 | 47.97 on 03/18/24 | ||
| 6-Month | |||||
| %Chg | +36.88% since 11/03/23 | +34.84% since 11/03/23 | +216.36% since 11/03/23 | ||
| Low | 51.21 on 11/09/23 | 13.39 on 11/10/23 | 8.43 on 11/10/23 | ||
| High | 94.57 on 02/27/24 | 37.00 on 03/04/24 | 47.97 on 03/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,308,399 | 1,359,509 | 1,293,483 | ||
| Shares Outstanding, K | 17,705 | 69,151 | 36,151 | ||
| Annual Sales | 131,310,000 | 0 | 890,000 | ||
| Annual Net Income | 52,150,000 | -151,760,000 | -338,790,000 | ||
| Last Quarter Sales | 28,100,000 | 0 | 0 | ||
| Last Quarter Net Income | 18,190,000 | -55,190,000 | -40,110,000 | ||
| 60-Month Beta | 1.01 | -0.29 | 2.93 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.05 on 02/27/24 | -0.99 on 02/29/24 | -2.28 on 02/29/24 | ||
| Latest Earnings Date | 05/07/24 | 05/20/24 | 05/09/24 | ||
| Most Recent Dividend | 2.500 on 04/03/07 | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 15.86 | 0.00 | 0.00 | ||